Back to calendar
Arbutus Biopharma Corporation (ABUS) Earnings
ABUS reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.02
Actual EPS: $0.87
EPS surprise: 3000.00%
Company overview
Market Cap$948.2M
PriceUSD 4.80
P/E5.84
EPS (TTM)0.82
52-week high5.38
52-week low3.08
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees19